logoOmicsDI
  • Browse
  • Submit Data
  • Databases
  • API

3 Results

Show all   Save search   Copy query

Show results for

  • UnknownUnknown (3)

Publication Date

Release Date

  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
UnknownRUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Not available
S-EPMC3295208 | biostudies-literature
UnknownChanging pattern of admissions for acute myocardial infarction in India during the COVID-19 pandemic.
Not available
S-EPMC8424286 | biostudies-literature
UnknownCommon Variable Immunodeficiency Disorder: A Decade of Insights from a Cohort of 150 Patients in India and the Use of Machine Learning Algorithms to Predict Severity.
Not available
S-EPMC12380919 | biostudies-literature
  • Previous page
  • 1 / 1
  • You're on page 1
  • Next page
Sort   by:  
Relevance
 Page size 
10
OmicsDI is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

EMBL-EBI logoEMBL-EBI logo

OmicsDI Databases

  • PRIDE
  • PeptideAtlas
  • MassIVE
  • JPOST Repository
  • Physiome Model Repository
  • EGA
  • EVA
  • ENA
  • LINCS
  • PAXDB
  • Cell Collective
  • MetaboLights
  • Metabolomics Workbench
  • MetabolomeExpress
  • GNPS
  • BioModels
  • FAIRDOMHub
  • ArrayExpress
  • dbGaP
  • ExpressionAtlas
  • GEO
  • NODE

Information

  • Databases
  • Help
  • API
  • Contact us
  • Code on GitHub
  • Terms of use
  • Submit Data